CMS Announces Proton System Agreement with ACCEL Instruments.Business Editors/Health/Medical Writers
ST. LOUIS--(BUSINESS WIRE)--Oct. 20, 2003
ACCEL ACCEL Accelerate
ACCEL Accelerando (Music, Gradually Increasing in Speed)
ACCEL American College of Cardiology Extended Learning Instruments GmbH, a global leader in design and manufacturing of particle accelerator particle accelerator, apparatus used in nuclear physics to produce beams of energetic charged particles and to direct them against various targets. Such machines, popularly called atom smashers, are needed to observe objects as small as the atomic nucleus in studies systems based in Bergisch Gladbach, near Cologne, Germany and CMS (1) See content management system and color management system.
(2) (Conversational Monitor System) Software that provides interactive communications for IBM's VM operating system. Inc., a global leader in the field of radiation oncology radiation oncology
The branch of radiology that deals with the use of ionizing radiation to treat cancers.
radiation oncology software based in St. Louis, MO, USA, are pleased to announce that they have finalized an agreement for the supply of treatment planning systems for the new Rinecker Proton Center (RPTC RPTC Rinecker Proton Therapy Center
RPTC Receiver Plain Text Clock
RPTC Roseville Park Tennis Club (Australia) ) of ProHealth AG in Munich, Germany. This will be the first all clinical proton therapy center in the Europe and it is designed to treat more than 4000 patients per year. The clinical start is scheduled for spring of 2005. ACCEL and CMS also agreed on options for additional centers that are currently being considered. The partnership between CMS and ACCEL furthermore intends to develop solutions for heavy ion treatment.
Proton therapy is a new, more precise form of advanced radiation treatment for cancer patients. It allows to treat cancer with an accuracy on millimeter scale while saving critical organs much better than other therapy procedures involving photons and electrons.
"CMS is the leader in radiation treatment planning worldwide. Proton and heavy ion therapy are areas where we see tremendous potential in providing leading edge technology for the benefit of patients worldwide. Solidifying our collaboration with ACCEL for the Rinecker Proton Therapy Center is an excellent step in the continued proliferation of proton therapy throughout the globe," commented Doug Sprague, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of CMS.
"As a leading supplier of accelerator technology and systems worldwide ACCEL is dedicated to proton therapy since over a decade. Our commitment and development work resulted in contracts for a compact superconducting 250 MeV cyclotron cyclotron: see particle accelerator.
Particle accelerator that accelerates charged atomic or subatomic particles in a constant magnetic field. for the Paul Scherrer Institute The Paul Scherrer Institute (PSI) is a multi-disciplinary research institute which belongs to the Swiss ETH-Komplex covering also the ETH Zurich and EPFL. It was established in 1988 by merging in 1960 established EIR (Eidgenössisches Institut für R (PSI) and the complete proton therapy system for the RPTC being established with our facility partner and general contractor M+W Zander zan·der
n. pl. zander or zan·ders
A common European pikeperch (Stizostedion lucioperca) valued as a food fish.
[German, from Low German Sander for ProHealth in Munich. We have developed strong collaborations with PSI and other leading partners in the field and are glad to start collaboration now with CMS for the benefit of cancer patients," said Hans-Udo Klein, Managing Director of ACCEL.
ACCEL Instruments GmbH is a specialized engineering and manufacturing company for custom designed research and industrial equipment operating worldwide. With a staff of about 100 specialists in the relevant technical areas, working together in project teams tailored for the individual customer's need, ACCEL is a leading supplier in the field.
CMS, Inc. is a world leader in the development and support of radiation treatment software. With more than 1,400 treatment planning systems installed worldwide, CMS is a global resource to radiation oncology departments for treatment planning software and prostate brachytherapy systems. A privately-held corporation, CMS employs 250 professionals in its headquarters located in St. Louis, MO and regional offices in Champaign, IL; Freiburg, Germany; Shanghai, China; and Tokyo, Japan. To learn more, visit www.cmsrtp.com or call 314-812-4320.